Nasopharyngeal Carcinoma Cell Proliferation

Nasopharyngeal carcinoma (NPC) cell proliferation refers to the abnormal growth and division of cancer cells originating from the epithelial cells of the nasopharyngeal mucosa. This is not a single molecular target but rather a cellular process that involves multiple molecular pathways and mechanisms, including key signaling pathways (PI3K/AKT, LKB1/AMPK, NF-κB, STAT3), viral factors (Epstein-Barr Virus, EBV-encoded LMP1, EBV-encoded circRNAs), and genetic factors (KISS1, HOXA10, miR-15b, SFPQ). Understanding these mechanisms provides potential therapeutic approaches for treating NPC by targeting these regulators.

Targeting the various signaling pathways (e.g., PI3K/AKT, LKB1/AMPK, NF-κB, STAT3), viral factors (e.g., EBV-encoded LMP1, circRNAs), and genetic factors (e.g., KISS1, HOXA10, miR-15b, SFPQ, TLR3) that regulate the abnormal growth and division of nasopharyngeal carcinoma cells to inhibit their proliferation, arrest cell cycle, or induce apoptosis.